C
Cured
We help bring healthcare forward by better connecting individuals and their families to care
About Cured
Cured.Health operates in the healthcare technology sector, providing advanced AI-driven tools designed to enhance clinical performance and patient engagement. The company primarily serves healthcare providers, including primary physicians and large healthcare organizations. Cured.Health's business model revolves around offering integrated technology solutions that streamline operations, improve data consistency, and facilitate better patient interactions. By leveraging artificial intelligence, the company helps healthcare professionals focus on patient care while automating administrative tasks such as documentation and knowledgebase searching. Revenue is generated through subscription fees for their software services and customized solutions tailored to client needs. The market for Cured.Health includes healthcare providers looking to modernize their operations and improve patient outcomes through technology.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2024 | $0 | — | InnovAccer | ↗ |
| SERIES A✓Equity / VC | Sep 2021 | $10M | $40M | High Alpha · Waterline Ventures · CU Healthcare Innovation Fund · Matchstick Ventures | — |
Growth signals
Latest recorded traffic for Cured is 4.5K monthly website visits, down 15.1% over the last three months. Cured's team declined 34.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Waterline Ventures
Matchstick Ventures
High Alpha
Series A4 investors entered at this stage
CU Healthcare Innovation Fund
UCHealth
DNA Capital
Headwater Ventures
Other known investors1 additional known investor
InnovAccer
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cured on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cured’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







